Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Muhammad Shahid, Tae Gyu Choi, Minh Nam Nguyen, Abel Matondo, Yong Hwa Jo, Ji Youn Yoo, Ngoc Ngo Yen Nguyen, Hyeong Rok Yun, Jieun Kim, Salima Akter, Insug Kang, Joohun Ha, Chi Hoon Maeng, Si-Young Kim, Ju-seog Lee, Jayoung Kim, Sung Soo Kim
Published Nov 15, 2016 · Vol. 7, No. 52 · pp. 86561-86572
Marcus Franz, Katja Grün, Stefan Betge, Ilonka Rohm, Bernadin Ndongson-Dongmo, Reinhard Bauer, P. Christian Schulze, Michael Lichtenauer, Iver Petersen, Dario Neri, Alexander Berndt, Christian Jung
Published Nov 8, 2016 · Vol. 7, No. 49 · pp. 81241-81254
Bryan P. Schneider, Dongbing Lai, Fei Shen, Guanglong Jiang, Milan Radovich, Lang Li, Laura Gardner, Kathy D. Miller, Anne O’Neill, Joseph A. Sparano, Gloria Xue, Tatiana Foroud, George W. Sledge Jr.
Published Oct 9, 2016 · Vol. 7, No. 50 · pp. 82244-82253